(Q46985870)

27 December 2017

title

Progress in the treatment of multiple myeloma (English)

1 reference

27 December 2017

author name string

Shaji Kumar

series ordinal

1

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

27 December 2017

published in

The Lancet

1 reference

27 December 2017

volume

367

1 reference

27 December 2017

issue

9513

1 reference

27 December 2017

page(s)

791-792

1 reference

27 December 2017

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

Drug insight: thalidomide as a treatment for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968311-6

7 January 2021

10.1016/S0140-6736(06)68311-6

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017